Détail de l'éditeur
Documents disponibles chez cet éditeur (463)
Rapport
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while high[...]Rapport
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report [...]Rapport
This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]Chapitre
This Selected issue is not intended to present a systematic and exhaustive review either of all possible definitions of drug-related public nuisance or of all measures, provisions and policies aimed at reducing the problem in the European Union,[...]Rapport
An update on the EMCDDA 2008 Selected Issue on drug-related research, this thematic paper identifies current and future challenges and opportunities for drug-related research in Europe.Rapport
OEDT = EMCDDA ; L. LANIEL ; R. KASECKER ; T. GROSHKOVA ; C. CARPENTIER | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Drug law enforcement activity targets the supply of drugs and is responsible for much of the key data that informs our understanding of drugs supply in Europe. This study looks, for the first time, at how drug law enforcement is organised in Eur[...]Rapport
OEDT = EMCDDA ; L. LANIEL ; T. SURMONT ; T. STOIAN ; S. ALM | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supp[...]Rapport
OEDT = EMCDDA ; E. QUIGLEY ; R. SEDEFOV ; C. CARPENTIER ; L. LANIEL ; European Commission, COWI Consortium for DG Health and Consumers | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013The production and trafficking of illicit drugs poses complex and interlinked problems, which have a negative impact on public health and the security and stability of society. Focusing on actions directed at the EU's internal security situation[...]Rapport
OEDT = EMCDDA ; L. AMATO ; Z. MITROVA ; M. DAVOLI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2017Although rare, drug testing in schools continues to be practised in some European countries. In many cases, drug testing is intended to act as a deterrent to substance use. Nevertheless, studies conducted in the United States show that the drug [...]Rapport
OEDT = EMCDDA ; R. KERT ; A. LEHNER ; B. HUGHES ; O. DALBINOE | Lisbon : OEDT / EMCDDA | Technical reports | 2017The results of a study on national drug trafficking laws and their application in the Member States of the European Union are presented in this report. It is based on an analysis of the national laws and on the opinions of legal practitioners - [...]Rapport
It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the drugs used and the need to provide on-g[...]Rapport
This report presents a summary of the key findings from drug treatment facility surveys carried out in 2017 in Albania, Bosnia and Herzegovina, Serbia and the territory of Kosovo. The results provide insight into the characteristics and capacity[...]Rapport
T. DECORTE ; D. MORTELMANS ; J. TIEBERGHIEN ; S. DE MOOR | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2009ENGLISH : In many European countries, one or more general population surveys have been carried out to get an impression of the characteristics of illicit drug use at national level. Despite valuable efforts to standardise national drug surveys[...]Rapport
The result of the EMCDDA's cooperation with countries in the Western Balkans over many years, this report is the first of its kind. It gives insight into the drug-related problems faced by six countries in the region, through the available data [...]Rapport
FRANÇAIS : Il semble que la consommation précoce de substances psychoactives, comme l'alcool et le tabac, soit associée avec un risque accru de développer des problèmes liés à la drogue par la suite. Dans cette « Question spécifique », publiée[...]Rapport
A. G. VERSTRAETE ; S. A. LEGRAND ; L. VANDAM ; B. HUGHES ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2014FRANÇAIS : Cette revue de la bibliographie nous propose un rapport détaillé sur la relation entre l'usage de drogues, la réduction des capacités de conduite et les accidents de la route. Le rapport examine des questions méthodologiques, présen[...]Rapport
E. RAES ; VAN DEN NESTE T. ; A. G. VERSTRAETE | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2008FRANÇAIS : Cette revue de la bibliographie nous propose un rapport détaillé sur la relation entre l'usage de drogues, la réduction des capacités de conduite et les accidents de la route. Le rapport examine des questions méthodologiques, présen[...]Rapport
OEDT = EMCDDA ; L. ROYUELA ; L. MONTANARI ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014The report presents a review of tools for monitoring illicit drug use in prison population in Europe. The objective of the report is to describe the existing tools used at national level, to assess their comparability and to build a common Europ[...]Rapport
This report is based on work commissioned by the EMCDDA in 2009. It examines differences in methods and results between general population surveys conducted in a single context (focusing exclusively on substance use) and a multi context (focusin[...]Rapport
Drug use is directly or indirectly prohibited in all EU countries - except for in medical or scientific circumstances - and punishment for offences varies from administrative to penal, depending on the country. This thematic paper analyses curre[...]Rapport
FRANÇAIS : Depuis la fin des années 1990, de nombreuses études européennes et mondiales ont abordé la problématique de la conduite sous l'influence de substances psychoactives. Dans cette « Question spécifique », publiée en marge de son Rappor[...]Rapport
This joint report prepared by the EMCDDA and Europol considers the latest findings from international research, fresh empirical data, and operational information and intelligence in order to illuminate how darknet markets function and how they r[...]Rapport
FRANÇAIS : La politique sociale en Europe a depuis longtemps identifié les populations défavorisées qui courent un risque d'exclusion sociale. Ces «groupes vulnérables» désignent des groupes spécifiques au sein de la population, qui sont plus [...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA ; T. NÉFAU ; E. LEFRANÇOIS ; T. SEYLER | Lisbon : OEDT / EMCDDA | Rapid communication | 2019This report presents the results of an innovative method for gathering information on the substances used by people who inject drugs. In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals t[...]Rapport
FRANÇAIS : Les problèmes liés à la drogue apparaissent souvent - et sont ressentis de la façon la plus aiguë - dans les environnements urbains, ce qui fait des villes d'Europe une précieuse fenêtre d'observation sur les nouvelles tendances du p[...]Congrès
Commission européenne = European Commission, Organisateur de réunion ; P. KENIS ; Drugs: Research related initiatives in the European Union (13 and 14 December 1996; The Robert Schuman centre, European University Institute, Florence) | Lisbon : OEDT / EMCDDA | Joint publications | 1997In 1996, representatives of the 15 Member States and individual researchers were invited to a joint seminar, organised by the European Commission and the EMCDDA, entitled 'Drug research-related initiatives in the European Union'. The seminar was[...]Rapport
Since the late 1990s, drug strategies and action plans have been increasingly adopted by EU countries as the central instrument for implementing drug policy. This thematic paper looks at the origins and characteristics of this phenomenon as well[...]Rapport
This paper presents a definition of e-health and m-heath tools to address substance use problems, and a taxonomy to describe such tools systematically. A number of examples of e-health tools that are currently being used in Europe for prevention[...]Rapport
OEDT = EMCDDA ; A. GALLEGOS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary network consisting of 30 Eu[...]Rapport
L. A. KING ; R. SEDEFOV ; Europol | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2007ENGLISH : The purpose of these guidelines is to address the measures introduced by Council Decision 2005/387/HA. They are concerned only with the first stage, i.e. the early-warning system and information exchange, and replace the earlier guid[...]Brochure
ENGLISH : Within the framework of the joint Action of 16 June 1997, the Early-warning System (EWS) aims to create a mechanism for the rapid exchange of information on the production, traffic, use and risks of new synthetic drugs. Taking into a[...]Rapport
European Centre for Disease Prevention and Control ; OEDT = EMCDDA | Lisbon : OEDT / EMCDDA | Joint publications | 2011FRANÇAIS : Sept interventions, un objectif : zéro infections parmi les personnes qui s’injectent des drogues. Dans un nouveau rapport d'orientation publié aujourd'hui, deux agences de l'UE, l'ECDC et l'OEDT, ont uni leurs efforts pour recenser [...]Congrès
The conference "Identifying Europes information needs for effective drug policy" marked the 15th anniversary of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), and our activity of monitoring drugs and drug addiction in the [...]Rapport
FRANÇAIS : Les nouvelles drogues officiellement signalées à l'OEDT et à Europol en 2009 via le système d'alerte précoce de l'UE sur les nouvelles substances psychoactives (Early-warning system/EWS) ont atteint un chiffre record. C'est ce qui se[...]Rapport
FRANÇAIS : De nouvelles substances psychoactives deviennent largement disponibles à un « rythme sans précédent ». En 2010, un nombre record de nouvelles drogues ont été officiellement signalées à l'OEDT et à Europol par le biais du système d'al[...]Rapport
FRANÇAIS : De nouvelles drogues ont été détectées dans l'Union européenne l'année dernière, à raison d'une par semaine environ, selon le rapport annuel conjoint de l'OEDT et d'Europol (2011) sur les nouvelles substances psychoactives publié auj[...]Rapport
FRANÇAIS : Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 201[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2014, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2017 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, i[...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide, commonly known as CUMYL-4CN-BINACA, through a joint assessment. The two or[...]Rapport
In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been [...]Rapport
In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as alpha-pyrrolidinovalerophenone (alpha-PVP), through a joint assessment. The two org[...]Rapport
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), through a joint assessment. The two organisat[...]Rapport
The EMCDDA-Europol Joint Report on new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine, commonly known by the abbreviation '25I-NBOMe', submitted in December 2013 to the Council of the EU, the European Commission an[...]Rapport
In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4′-DMAR). The two organisations concluded th[...]Rapport
At the end of 2011 and in 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methylamphetamine. The two organisations concluded that sufficient information had been accumulated to merit the product[...]